SecBot SecBot
SECBOTREPLAY Home › Report › CME

CME · Director Daniel G

CME GROUP INC. · 144 filed Nov 9, 2026 at 15:55 ET

At the news

NEUTRALIMPACT 1/10

144 filed Nov 9, 2026 at 15:55 ET

Director Daniel G. Kaye filed a Form 144 notice of intent to sell 532 shares of CME Group common stock, valued at approximately $163,324. The shares were acquired via a stock award on June 25, 2025, and the sale is planned for November 9, 2026. This is a very small sale relative to the company's $110.1B market cap and the insider's likely total holdings, making it a routine, low-significance event.

  • Insider: Director Daniel G. Kaye
  • Shares to be sold: 532 shares of common stock
  • Approximate value: $163,324
  • Shares acquired on June 25, 2025 via stock award (compensation)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access